Other OTC - Delayed Quote USD

BioCorRx Inc. (BICX)

0.7500 -0.0700 (-8.54%)
At close: 11:36 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
89.1600
89.1600
213.8410
48.2720
122.6210
Cost of Revenue
35.9860
35.9860
15.2790
5.8810
95.9480
Gross Profit
53.1740
53.1740
198.5620
42.3910
26.6730
Operating Expense
2,859.9940
2,859.9940
3,107.0610
4,575.0940
3,054.0200
Operating Income
-2,806.8200
-2,806.8200
-2,908.4990
-4,532.7030
-3,027.3470
Net Non Operating Interest Income Expense
-886.6270
-886.6270
-1,086.7750
-565.6840
-510.9590
Other Income Expense
-77.0430
-77.0430
-381.5580
-112.2510
31.7990
Pretax Income
-3,770.4900
-3,770.4900
-4,376.8320
-5,210.6380
-3,506.5070
Net Income Common Stockholders
-3,766.9130
-3,766.9130
-4,369.4130
-5,278.3810
-3,472.2310
Diluted NI Available to Com Stockholders
-3,766.9130
-3,766.9130
-4,369.4130
-5,278.3810
-3,472.2310
Basic EPS
-0.45
--
-0.61
-0.81
-0.65
Diluted EPS
-0.45
--
-0.61
-0.81
-0.65
Basic Average Shares
8,344.0790
--
7,198.3120
6,491.0670
5,377.6700
Diluted Average Shares
8,344.0790
--
7,198.3120
6,491.0670
5,377.6700
Total Operating Income as Reported
-3,787.7960
-3,787.7960
-4,697.9950
-5,510.1070
-7,491.9730
Total Expenses
2,895.9800
2,895.9800
3,122.3400
4,580.9750
3,149.9680
Net Income from Continuing & Discontinued Operation
-3,766.9130
-3,766.9130
-4,369.4130
-5,208.2540
-3,472.2310
Normalized Income
-3,684.5950
-3,684.5950
-4,170.4740
-5,066.7740
-3,472.2310
Interest Expense
886.6270
886.6270
1,086.7750
565.6840
510.9590
Net Interest Income
-886.6270
-886.6270
-1,086.7750
-565.6840
-510.9590
EBIT
-2,883.8630
-2,883.8630
-3,290.0570
-4,644.9540
-2,995.5480
EBITDA
-2,683.9270
-2,683.9270
-3,148.0920
-4,476.0110
-2,828.7770
Reconciled Cost of Revenue
35.9860
35.9860
15.2790
5.8810
6.4310
Reconciled Depreciation
199.9360
199.9360
141.9650
168.9430
166.7710
Net Income from Continuing Operation Net Minority Interest
-3,766.9130
-3,766.9130
-4,369.4130
-5,208.2540
-3,472.2310
Total Unusual Items Excluding Goodwill
-82.3180
-82.3180
-198.9390
-141.4800
--
Total Unusual Items
-82.3180
-82.3180
-198.9390
-141.4800
--
Normalized EBITDA
-2,601.6090
-2,601.6090
-2,949.1530
-4,334.5310
-2,828.7770
12/31/2020 - 8/31/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade